| 2026-10-26 17:00 |
8-K |
["1.01"] |
material agreement |
0.85
|
DataMeds AI entering non-binding LOI for multi-asset acquisition including IP, licenses, and controlling stake in health company. |
SEC · detail |
| 2026-10-20 09:24 |
8-K |
["7.01", "8.01", "9.01"] |
other |
0.05
|
Nasdaq compliance restoration announcement; no M&A signals present. |
SEC · detail |
| 2026-10-16 17:15 |
8-K |
["1.01", "3.01", "3.02"] |
material agreement |
0.15
|
IP license agreement with REBOOT Health AI; no M&A signals. Company addresses Nasdaq delisting deficiency via equity issuances. |
SEC · detail |
| 2026-10-13 17:27 |
8-K |
["8.01"] |
other |
0.15
|
Settlement of litigation and licensing agreement with REBOOT Health AI; no M&A signal. |
SEC · detail |
| 2026-09-17 17:23 |
8-K |
["8.01"] |
other |
0.05
|
Settlement agreement resolving litigation regarding prior acquisition (MIPA) and share repurchase; no M&A transaction indicated. |
SEC · detail |
| 2026-09-16 17:11 |
8-K |
["1.01"] |
material agreement |
0.15
|
DataMeds AI acquired Helomics subsidiary; not a signal of DataMeds being M&A target. |
SEC · detail |
| 2026-08-18 07:43 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine 8-K filing announcing Q2 2026 financial results and business update; no M&A signals. |
SEC · detail |
| 2026-08-14 16:46 |
8-K |
["8.01"] |
other |
0.05
|
8-K Item 8.01 announces a meme coin distribution to shareholders; unrelated to M&A. |
SEC · detail |
| 2026-08-04 16:30 |
8-K |
["1.01"] |
material agreement |
0.85
|
DataMeds AI entered into Amended & Restated LOI for acquisition of IP assets, exclusive licensing, and controlling interest in Tollo Health with 84.6% dilution. |
SEC · detail |
| 2026-07-28 19:14 |
8-K |
["8.01", "9.01"] |
other |
0.00
|
8-K announces Dream Bowl 2026 Meme Coin distribution record date update; no M&A signals. |
SEC · detail |